Initial CDEs developed by NIH, DCRI, UNC
- Version 1.0 released for feedback
• Oct. 16, 2020: RADx-UP CDCC launched
- Began collecting feedback from projects
• Nov. 2020: Version 1.1 released incorporating feedback
- Continued feedback collection
• Jan. 2021: Version 1.2 released with Spanish translation
- Added new elements based on project needs
- Began testing data collection tool prototypes
• April 2022: Version 1.5 released
- Major revision based on 2 years of implementation experience
- Streamlined elements and response options
- Added new elements (e.g., vaccination
RADx-UP CDCC presentation for the NIH Disaster Interest GroupWarren Kibbe
Presentation on the RADx-Underserved Populations Coordination and Data Collection Center with an emphasis on how it will help understand and reduce the disparities associated with the COVDI-19 pandemic
The webinar will include an introduction to COVID-END and an overview of how COVID-END’s resources can support you in your response to COVID-19. With tips, tools, and a guide to evidence sources for both researchers and decision-makers, COVID-END has something for everyone.
Africa CDC, FIND partner to build capacity for COVID-19 rapid diagnostic test...SABC News
The Foundation for Innovative New Diagnostics (FIND) and the Africa Centres for Disease Control and Prevention (Africa CDC) have announced a new partnership to build capacity in readiness for the introduction of new, high-quality antigen rapid diagnostic tests (RDTs) for COVID-19 that are anticipated to become available soon
Co-ordinated malaria research for better policy and practice: the role of res...ACT Consortium
Prof. David Schellenberg from the London School of Hygiene & Tropical Medicine presents on behalf of the ACT Consortium at the European Congress on Tropical Medicine and International Health in Basel, Switzerland, 8 September 2015
Canada’s Rare Disease Drug Program
Vision: Integrated, Inclusive, Innovative Rare Drug System
Single Seamless Pathway from R&D, CT, regulatory approval, access parameters, monitoring, values-based assessment, price negotiations
Governance board representing all stakeholders: diverse patient community, clinical specialities, public/private drug plan providers, HTA agencies, pharmaceutical companies, subject matter experts (regulatory, research)
Building for Success: 12 Steps, 4 Platforms
RADx-UP CDCC presentation for the NIH Disaster Interest GroupWarren Kibbe
Presentation on the RADx-Underserved Populations Coordination and Data Collection Center with an emphasis on how it will help understand and reduce the disparities associated with the COVDI-19 pandemic
The webinar will include an introduction to COVID-END and an overview of how COVID-END’s resources can support you in your response to COVID-19. With tips, tools, and a guide to evidence sources for both researchers and decision-makers, COVID-END has something for everyone.
Africa CDC, FIND partner to build capacity for COVID-19 rapid diagnostic test...SABC News
The Foundation for Innovative New Diagnostics (FIND) and the Africa Centres for Disease Control and Prevention (Africa CDC) have announced a new partnership to build capacity in readiness for the introduction of new, high-quality antigen rapid diagnostic tests (RDTs) for COVID-19 that are anticipated to become available soon
Co-ordinated malaria research for better policy and practice: the role of res...ACT Consortium
Prof. David Schellenberg from the London School of Hygiene & Tropical Medicine presents on behalf of the ACT Consortium at the European Congress on Tropical Medicine and International Health in Basel, Switzerland, 8 September 2015
Canada’s Rare Disease Drug Program
Vision: Integrated, Inclusive, Innovative Rare Drug System
Single Seamless Pathway from R&D, CT, regulatory approval, access parameters, monitoring, values-based assessment, price negotiations
Governance board representing all stakeholders: diverse patient community, clinical specialities, public/private drug plan providers, HTA agencies, pharmaceutical companies, subject matter experts (regulatory, research)
Building for Success: 12 Steps, 4 Platforms
AIDS and its vengeance saw a back seat after we achieved the zero level of growth for it. But worries regarding the people living with AIDS are still on and we need to take care of these segments in an integrated manner
Repurposed existing drugs and updated global health policy and clinical guidelines will be essential for limiting the social and economic devastation caused by this virus. So, we are leading a three-phase multinational Network Medicine clinical study (MNM COVID-19 study). The study will apply Network Medicine methodologies to repurpose existing drugs for SARS-CoV-2 infected patients and update global health policy and clinical guidelines.
Digital transformation to enable a FAIR approach for health data scienceVarsha Khodiyar
Invited talk for ConTech Pharma on 1st March 2022
Abstract
Health Data Research UK is the UK’s national institute for health data science, with a mission to unite the UK’s health data to enable discoveries that improve people’s lives. In this talk, Dr Varsha Khodiyar will outline how HDR UK is bringing together disparate health data from all four countries of the United Kingdom, creating the infrastructure to enable discovery of and access to health data, and the convening standards making bodies to improve data linkage and data reuse. Varsha will also discuss how HDR UK is moving beyond the traditional confines of FAIR data to also ensure that data sharing and data use is transparent and ‘fair’ for the patients and lay public who are the subjects of these datasets.
#COVIDaction, a partnership between DFID’s Frontier Technology Hub, Global Disability (GDI) Hub, UCL Institute of Healthcare Engineering along with other collaborators will be working to build a technology and innovation pipeline to support action related to the COVID pandemic.
Long-Range Research Initiative
- Global Research Strategy
21st Century Approaches to Risk Sciences
The Long-Range Research Initiative (LRI) of the American Chemistry Council (ACC) promotes innovations in chemical safety assessment. It invests in science essential for understanding the impact of chemicals on human health and the environment.
LRI’s mission is to foster a sustainable and healthy future through support of high quality science that targets the science-policy interface and advances the science used in decision-making.
Global Initiatives :
Science that advances chemical management practices for a global economy.
ANALYZING THE EFFECTS OF DIFFERENT POLICIES AND STRICTNESS LEVELS ON MONTHLY ...IJDKP
The corona virus is one of the most unprecedented events of recent decades. Countries struggled to identify
appropriate COVID-19 policies to prevent virus spread effectively. Although much research has been
done, little focused on policy effectiveness and their enforcement levels. As corona virus cases and death
numbers fluctuated among countries, questions of which policies are most effective in preventing corona
virus spread and how strict they should be implemented have yet to be answered. Countries are prone to
making policy and implementation errors that could cost lives. This research identified the most effective
policies and their most effective enforcement levels through data analysis of 12 common coronavirus
policies. A monthly case increase rate prediction model was developed to enable decision makers to
evaluate the effectiveness of COVID-19 policies and their enforcement levels so that they can implement
policies efficiently to save lives, time, and money.
Lessons from the UK: Data access, patient trust & real-world impact with heal...Varsha Khodiyar
Slides supporting presentation given at the virtual Beilstein Open Science Symposium in October 2021.
Abstract:
Health Data Research UK’s mission is to unite the UK’s health data to enable discoveries that improve people’s lives. Our 20-year vision is for large scale data and advanced analytics to benefit every patient interaction, clinical trial, biomedical discovery and enhance public health. A key part of HDR UK’s vision is our data portal, the Innovation Gateway. The Gateway facilitates discovery of healthcare data and simplifies data request procedures across multiple data custodians. The Gateway contains metadata on a variety of datasets, including those related to COVID-19, cardiovascular, maternal health, emergency care, primary care, secondary care, acute care, palliative care, biobanks, research cohorts and deeply phenotyped patient cohorts.
From the outset HDR UK has sought the voices, views and experiences of patient and lay-public groups to ensure there is transparency and clear public benefit in the use of the UK’s health data. Patient and public involvement is key to making the Gateway accessible, transparent and to ensure public confidence in research access to health data. The importance of public outreach combined with providing research access to data is illustrated with HDR UK’s contribution to the UK’s coronavirus pandemic response. HDR UK was tasked by the UK’s Chief Scientific Office to build and facilitate the infrastructure to support the National Core Studies, providing key insights on the evolving situation to UK policy makers during the course of the pandemic.
In this talk, I will show how HDR UK is enabling open science by facilitating the discovery of health data, and simplifying the process of requesting access to multiple datasets. I’ll discuss HDR UK’s approach to embedding transparency on research data usage for patients and public, and summarise some of the key ways in which HDR UK has contributed to the coronavirus pandemic.
Rare Disease Patient Registries:
Key to Drug Development and Access
Tuesday, May 3 @ 12:00 – 1:00 pm EDT
Slides:
USA National Institutes of Health RaDaR
NORD IAMRARE (Pam Gavin, VP)
Canada INFORM RARE (Beth Potter, CHEO; Pranesh Chakraborty, CHEO; Kim Angel, Can MPS Society; John Adams, CanPKU)
EuroBioForum 2013 - Day 1 | Etienne RicherEuroBioForum
EuroBioForum 2013 2nd Annual Conference
27-28 May 2013 - Hilton Munich City, Munich, Germany
http://www.eurobioforum.eu/2013
=======================================
# NATIONAL PERSPECTIVES #
Canada:
Personalised Medicine: A Canadian Collaborative Perspective'
Dr Étienne Richer, Assistant Director at CIHR Institute of Genetics
=======================================
http://www.eurobioforum.eu
A VIVO VIEW OF CANCER RESEARCH: Dream, Vision and RealityPaul Courtney
Presentation made by Paul Courtney (Dana-Farber Cancer Institute, Boston, MA and OHSL, MD) and Anil Srivastava (OHSL) at the 2013 VIVO conference in St. Louis, MO. Material contributed by Rubayi Srivastava (OHSL), Swati Mehta (Centre for Development of Advanced Computing, India), Juliusz Pukacki (Poznan Supercomputing and Network Center, Poland) and Devdatt Dubhashi (Chalmers Institute of Technology, Sweden).
How Community Engagement Fits Into The Mission Of The National Center for Adv...SC CTSI at USC and CHLA
Christopher Austin, MD, Director of the National Center for Advancing Translational Sciences (NCATS) shared his thoughts on how community engagement fits into the mission of NCATS at the recent CTSA Community Engagement Key Function Committee (KFC) conference. He proposed a revision of NCATS' mission: "To catalyze the generation of innovative methods and technologies that will enhance the development, testing and implementation of interventions that tangibly improve human health across a wide range of human diseases and conditions." Learn more about NCATS http://www.ncats.nih.gov/
The IMI EHDEN project: large-scale analysis of observation data in Europe - C...Maxim Moinat
The European Health Data & Evidence Network (EHDEN) project, funded via the Innovative Medicines Initiative (IMI), is the largest of its kind in Europe working in the domain of RWD/RWE. It is a public private partnership consortium of 22 partners, from 2018 to 2024, led by Erasmus Medical Center (EMC) and Janssen, working to create an open science community symbiotic with the Observational Health Data Science and Informatics (OHDSI) global framework to facilitate observational/RWD-based research at scale and acceleration, without impinging on quality. At its core is the standardisation of RWD via use of the Observational Medical Outcomes Partnership (OMOP) common data model (CDM), standardised analytics and a sustainable research community for the coming decades. Potentially, between EHDEN and OHDSI there are several use cases developed on the boundaries between clinical trials and observational data, and we look forward discussing these with the CDISC community.
The FDA Digital Health Center of Excellence and the Advancement of Digital He...Greenlight Guru
The FDA Digital Health Center of Excellence is part of the planned evolution of the digital health program with the intent to drive synergy for digital health efforts, align strategy with implementation, prepare the FDA for the digital health future, and protect patients and maintain the FDA standards of safety and effectiveness.
Ultimately, the program works to strategically advance science and evidence for digital health technologies that meets the needs of
stakeholders.
This free in-depth webinar, presented by Matthew DiamondChief Medical Officer, Digital Health Center of Excellence, will cover the digital health landscape and areas of application, goals and outcomes, planned services and launch plan, and the current areas of focus - including AI/ML-Based SaMD.
This presentation originally aired during the 2021 State of Medical Device Virtual Summit.
AIDS and its vengeance saw a back seat after we achieved the zero level of growth for it. But worries regarding the people living with AIDS are still on and we need to take care of these segments in an integrated manner
Repurposed existing drugs and updated global health policy and clinical guidelines will be essential for limiting the social and economic devastation caused by this virus. So, we are leading a three-phase multinational Network Medicine clinical study (MNM COVID-19 study). The study will apply Network Medicine methodologies to repurpose existing drugs for SARS-CoV-2 infected patients and update global health policy and clinical guidelines.
Digital transformation to enable a FAIR approach for health data scienceVarsha Khodiyar
Invited talk for ConTech Pharma on 1st March 2022
Abstract
Health Data Research UK is the UK’s national institute for health data science, with a mission to unite the UK’s health data to enable discoveries that improve people’s lives. In this talk, Dr Varsha Khodiyar will outline how HDR UK is bringing together disparate health data from all four countries of the United Kingdom, creating the infrastructure to enable discovery of and access to health data, and the convening standards making bodies to improve data linkage and data reuse. Varsha will also discuss how HDR UK is moving beyond the traditional confines of FAIR data to also ensure that data sharing and data use is transparent and ‘fair’ for the patients and lay public who are the subjects of these datasets.
#COVIDaction, a partnership between DFID’s Frontier Technology Hub, Global Disability (GDI) Hub, UCL Institute of Healthcare Engineering along with other collaborators will be working to build a technology and innovation pipeline to support action related to the COVID pandemic.
Long-Range Research Initiative
- Global Research Strategy
21st Century Approaches to Risk Sciences
The Long-Range Research Initiative (LRI) of the American Chemistry Council (ACC) promotes innovations in chemical safety assessment. It invests in science essential for understanding the impact of chemicals on human health and the environment.
LRI’s mission is to foster a sustainable and healthy future through support of high quality science that targets the science-policy interface and advances the science used in decision-making.
Global Initiatives :
Science that advances chemical management practices for a global economy.
ANALYZING THE EFFECTS OF DIFFERENT POLICIES AND STRICTNESS LEVELS ON MONTHLY ...IJDKP
The corona virus is one of the most unprecedented events of recent decades. Countries struggled to identify
appropriate COVID-19 policies to prevent virus spread effectively. Although much research has been
done, little focused on policy effectiveness and their enforcement levels. As corona virus cases and death
numbers fluctuated among countries, questions of which policies are most effective in preventing corona
virus spread and how strict they should be implemented have yet to be answered. Countries are prone to
making policy and implementation errors that could cost lives. This research identified the most effective
policies and their most effective enforcement levels through data analysis of 12 common coronavirus
policies. A monthly case increase rate prediction model was developed to enable decision makers to
evaluate the effectiveness of COVID-19 policies and their enforcement levels so that they can implement
policies efficiently to save lives, time, and money.
Lessons from the UK: Data access, patient trust & real-world impact with heal...Varsha Khodiyar
Slides supporting presentation given at the virtual Beilstein Open Science Symposium in October 2021.
Abstract:
Health Data Research UK’s mission is to unite the UK’s health data to enable discoveries that improve people’s lives. Our 20-year vision is for large scale data and advanced analytics to benefit every patient interaction, clinical trial, biomedical discovery and enhance public health. A key part of HDR UK’s vision is our data portal, the Innovation Gateway. The Gateway facilitates discovery of healthcare data and simplifies data request procedures across multiple data custodians. The Gateway contains metadata on a variety of datasets, including those related to COVID-19, cardiovascular, maternal health, emergency care, primary care, secondary care, acute care, palliative care, biobanks, research cohorts and deeply phenotyped patient cohorts.
From the outset HDR UK has sought the voices, views and experiences of patient and lay-public groups to ensure there is transparency and clear public benefit in the use of the UK’s health data. Patient and public involvement is key to making the Gateway accessible, transparent and to ensure public confidence in research access to health data. The importance of public outreach combined with providing research access to data is illustrated with HDR UK’s contribution to the UK’s coronavirus pandemic response. HDR UK was tasked by the UK’s Chief Scientific Office to build and facilitate the infrastructure to support the National Core Studies, providing key insights on the evolving situation to UK policy makers during the course of the pandemic.
In this talk, I will show how HDR UK is enabling open science by facilitating the discovery of health data, and simplifying the process of requesting access to multiple datasets. I’ll discuss HDR UK’s approach to embedding transparency on research data usage for patients and public, and summarise some of the key ways in which HDR UK has contributed to the coronavirus pandemic.
Rare Disease Patient Registries:
Key to Drug Development and Access
Tuesday, May 3 @ 12:00 – 1:00 pm EDT
Slides:
USA National Institutes of Health RaDaR
NORD IAMRARE (Pam Gavin, VP)
Canada INFORM RARE (Beth Potter, CHEO; Pranesh Chakraborty, CHEO; Kim Angel, Can MPS Society; John Adams, CanPKU)
EuroBioForum 2013 - Day 1 | Etienne RicherEuroBioForum
EuroBioForum 2013 2nd Annual Conference
27-28 May 2013 - Hilton Munich City, Munich, Germany
http://www.eurobioforum.eu/2013
=======================================
# NATIONAL PERSPECTIVES #
Canada:
Personalised Medicine: A Canadian Collaborative Perspective'
Dr Étienne Richer, Assistant Director at CIHR Institute of Genetics
=======================================
http://www.eurobioforum.eu
A VIVO VIEW OF CANCER RESEARCH: Dream, Vision and RealityPaul Courtney
Presentation made by Paul Courtney (Dana-Farber Cancer Institute, Boston, MA and OHSL, MD) and Anil Srivastava (OHSL) at the 2013 VIVO conference in St. Louis, MO. Material contributed by Rubayi Srivastava (OHSL), Swati Mehta (Centre for Development of Advanced Computing, India), Juliusz Pukacki (Poznan Supercomputing and Network Center, Poland) and Devdatt Dubhashi (Chalmers Institute of Technology, Sweden).
How Community Engagement Fits Into The Mission Of The National Center for Adv...SC CTSI at USC and CHLA
Christopher Austin, MD, Director of the National Center for Advancing Translational Sciences (NCATS) shared his thoughts on how community engagement fits into the mission of NCATS at the recent CTSA Community Engagement Key Function Committee (KFC) conference. He proposed a revision of NCATS' mission: "To catalyze the generation of innovative methods and technologies that will enhance the development, testing and implementation of interventions that tangibly improve human health across a wide range of human diseases and conditions." Learn more about NCATS http://www.ncats.nih.gov/
The IMI EHDEN project: large-scale analysis of observation data in Europe - C...Maxim Moinat
The European Health Data & Evidence Network (EHDEN) project, funded via the Innovative Medicines Initiative (IMI), is the largest of its kind in Europe working in the domain of RWD/RWE. It is a public private partnership consortium of 22 partners, from 2018 to 2024, led by Erasmus Medical Center (EMC) and Janssen, working to create an open science community symbiotic with the Observational Health Data Science and Informatics (OHDSI) global framework to facilitate observational/RWD-based research at scale and acceleration, without impinging on quality. At its core is the standardisation of RWD via use of the Observational Medical Outcomes Partnership (OMOP) common data model (CDM), standardised analytics and a sustainable research community for the coming decades. Potentially, between EHDEN and OHDSI there are several use cases developed on the boundaries between clinical trials and observational data, and we look forward discussing these with the CDISC community.
The FDA Digital Health Center of Excellence and the Advancement of Digital He...Greenlight Guru
The FDA Digital Health Center of Excellence is part of the planned evolution of the digital health program with the intent to drive synergy for digital health efforts, align strategy with implementation, prepare the FDA for the digital health future, and protect patients and maintain the FDA standards of safety and effectiveness.
Ultimately, the program works to strategically advance science and evidence for digital health technologies that meets the needs of
stakeholders.
This free in-depth webinar, presented by Matthew DiamondChief Medical Officer, Digital Health Center of Excellence, will cover the digital health landscape and areas of application, goals and outcomes, planned services and launch plan, and the current areas of focus - including AI/ML-Based SaMD.
This presentation originally aired during the 2021 State of Medical Device Virtual Summit.
Similar to RADx-UP CDCC Overview November 2022 (20)
Data Harmonization for a Molecularly Driven Health SystemWarren Kibbe
Maximizing the value of data, computing, data science in an academic medical center, or 'towards a molecularly informed Learning Health System. Given in October at the University of Florida in Gainesville
Data Harmonization for a Molecularly Driven Health SystemWarren Kibbe
Seminar for Dr. Min Zhang's Purdue Bioinformatics Seminar Series. Touched on learning health systems, the Gen3 Data Commons, the NCI Genomic Data Commons, Data Harmonization, FAIR, and open science.
Drivers for data sharing in funding of biomedical research. Importance of data sharing on open science, innovation, reproducibility that is enabled by digital technologies and data science.
Data in precision oncology SAMSI Precision Medicine Meeting mar 2019Warren Kibbe
Talk at the March 14-15 2019 SAMSI Advances in Precision and Personalized Medicine held as part of the Program on Statistical, Mathematical, and Computational Methods for Precision Medicine (PMED) at NCSU, Raleigh, NC
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Best Ayurvedic medicine for Gas and IndigestionSwastikAyurveda
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAkankshaAshtankar
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
2. RADx Underserved
Populations
(RADx-UP)
Understand and reduce the
disparities in COVID-19
morbidity and mortality for
those disproportionately
affected by COVID-19
This is us
BUDGET
$533 Million
RADxTech
Speed innovative point-of-
care, home-based, and
clinical laboratory tests for
COVID-19
BUDGET
$908 Million
RADx Advanced
Technology Platforms
(RADx-ATP)
Identify testing platforms
that are far enough advanced
for rapid scale-up or
expanded geographical
placement
BUDGET
$230 Million
RADx Radical
(RADx-rad)
Support new, non-
traditional approaches
to address current testing
gaps, and non-traditional
applications of existing
approaches
BUDGET
$187 Million
RADx-UP is Part of a $1.4 Billion NIH Initiative
3. RADx-UP is Community-Engaged Research
• Overarching goal is to evaluate strategies to increase uptake
and access to COVID-19 tests in underserved populations
• NIH started RADx-UP in September 2020, with awards in phases:
– Fall 2020: Phase 1 (69 projects) and CDCC
– Spring/Summer 2021: SayYes! COVIDTest and the Safe Return
to School DiagnosticTesting Initiative (16 projects)
– Fall/Winter 2021: Phase 2 (21 projects) and Supplemental (21 projects)
– Fall 2022: Additional Phase 3 projects expected
• RADx-UP projects build on existing community-academic
infrastructure, processes, and relationships
4. Take home messages
• The RADx-UP Coordination and Data Collection Center (CDCC) is a joint
collaboration of DCRI, UNC Chapel Hill, and the Community-Campus
Partnerships for Health. Started in September 2020.
• RADx-UP CDCC leverages the Secure Duke Azure Cloud
• We coordinate 135+ NIH funded projects and 40 funded pilot projects
• We are partnering with many communities throughout the country and use
data to drive and enhance those relationships
• Meetings: weekly with every project, project-wide every month, NIH every two
weeks, working groups, committees, hold scientific meetings, and organize an
annual equity evidence academy meeting
5. 5
Program Overview
Phase I: Established a consortium of community-engaged research projects focused primarily on
increasing access to and uptake of COVID-19 diagnostic testing
Phase II: Expanded Phase I infrastructure, built in projects with an emphasis on interventions, including
a specific focus on school settings, and incorporated research to address vaccine hesitancy and
uptake
Target Population: populations with health disparities, underserved and vulnerable groups
Overarching Goal
The overarching goal of RADx-UP is to understand factors that have led to the
disproportionate burden of the pandemic on underserved populations, so that COVID-
19 testing interventions can be developed and implemented to decrease these
disparities.
RADx-UP Phase I and II
6. RADx-UP Phase III
Leverage rapid, self-
administeredCOVID-19
testing to understand and
address COVID-19
morbidity and mortality
disparities among the
underserved and vulnerable
populations, given the
availability of COVID-19
vaccines
Study secondary impacts of
mandates for mitigation
measures associated with
COVID-19 and support
psychological and
communication science
interventions to improve
uptake of testing and
vaccination
Expand the evidence base of
scalable and sustainable
approaches to safely maintain
students in school. Integrate
new “Test-to-Stay” models that
reduce or avoid quarantine and
disruptions to the school
environment
TESTING SEBI SAFE IN SCHOOL
Goal: Address the evolving challenges of the pandemic with a focus on developing rapid testing
strategies for use with other mitigation efforts (e.g., vaccination, physical mitigation measures) to reduce
COVID-19 disparities.
8. Case Rates for Vulnerable Populations
CDC COVID Data Tracker
Race/Ethnicity
https://covid.cdc.gov/covid-data-tracker/#demographicsovertime
alpha
delta
omicron
9. Death Rates for Vulnerable Populations
CDC COVID Data Tracker
Race/Ethnicity
https://covid.cdc.gov/covid-data-tracker/#demographicsovertime
alpha
delta
omicron
10. 10
RADx-UP CDCC
Goals
Accelerate COVID-19 community implementation
implementation science via an agile, flexible,
flexible, participatory, transparent and sustainable
sustainable CDCC.
Support data collection, integration, and
integration, and sharing while preserving
preserving necessary data protections.
Amplify and disseminate community best practices
practices for successful implementation of COVID-
COVID-19 testing strategies and vaccines.
Utilize RADx-UP infrastructure to
support COVID-19 research.
11. 11
Sept – Nov 2020
Phase I Phase II
Build
infrastructure
Rapidly
implement
testing, other
capabilities
Integrate
new
advances
Investigate social,
ethical, &
behavioral barriers
to testing
RADx-UP Phases and Timeline
Phase III
Expand
studies/
populations
2022
Overarching Goals
Enhance COVID-19 testing among underserved and vulnerable populations across the US
Develop/create a consortium of community-engaged research projects designed to rapidly implement testing interventions
Strengthen the available data on disparities in infection rates, disease progression and outcomes, and identify strategies to reduce these
disparities in COVID-19 diagnostics
Through better testing, RADx-UP will help researchers see a clearer picture of how COVID-19 affects these populations and how to improve
health outcomes around the virus
Expand the evidence base of scalable and sustainable approaches to safely maintain students in school
Emphasis on
Rapid Testing
and Testing in
Schools
Jan – Nov 2021
School based
studies
13. 13
Communities served by RADx-UP projects
Self-reported data reflects RADx-UP Phase I and II projects as of 10/20/2021
14. 14
The RADx-UP Coordination
and Data Collection Center (CDCC)
The CDCC serves as a hub for all RADx-UP funded projects.
The CDCC supports RADx-UP projects to optimize engagement, outreach,
testing strategies, data collection and integration, and co-learning
opportunities between and among project teams and to the communities
that we serve.
The CDCC is led by the Duke Clinical Research Institute (DCRI), and the
Center for Health Equity Research at UNC-Chapel Hill with support from
a key partner, Community-Campus Partnerships for Health.
15. 15
RADx-UP is the largest single NIH investment in understanding the factors
that protect or harm underserved communities.
RADx-UP projects are required to collect the NIH RADx-UP Common Data
Elements (CDEs) in order to capture consistent data for comparison across
studies.
The CDCC supports projects in aligning your activities with requirements to
make data findable, accessible, interoperable and reusable (FAIR).
The RADx-UP aggregated data will be a resource for NIH, communities, and
researchers to understand the impact of COVID-19 on the well-being, risk,
resilience, and disparities in underserved and vulnerable communities.
NIH Vision for RADx-UP Data
16. The RADx-UP Coordination and Data Collection Center (CDCC)
Al Richmond, MSW
Community
Engagement Core
Community-Campus
Partnerships for Health
Susan Knox, MBA
CDCC Program Manager
Chris Woods, MD
COVID-19 Testing Core
Michael Cohen-
Wolkowiez,
MD, PhD
Duke Clinical Research
Institute (DCRI)
Principal Investigators
Giselle Corbie,
MD, MSc
UNC Center for Health
Equity Research
Warren A. Kibbe,
PhD, FACMI
Duke Department of
Biostatistics and
Bioinformatics
Core Leaders
100+ operational
& support staff
- Experienced
- Diversity of
backgrounds
and training
- Dedicated
Engagement Impact
Teams
Keith Marsolo, PhD
Data Science &
Biostatistics Core
Lisa Wruck, PhD
Data Science &
Biostatistics Core
Krista Perreira, PhD
Community
Engagement Core
Operations Key Partner
Al Richmond, MSW
Community-Campus
Partnerships for Health
17. 17
RADx-UP CDCC - Guiding Principles
Communities are at the center of our work.
Data sovereignty protections, and sharing with communities
and participants, are essential in building trust and being
trustworthy.
Intentional support of study teams is critical to streamline
results and troubleshoot.
Broad dissemination of program activities, data, and best
practices are key.
Strategic partnerships will augment community benefits from
the program.
Impact will be broad and will inform national guidance, strategy,
and response to COVID-19.
18. 18
Administration &
Coordination
Communication
Committee oversight
Processes, policies,
procedures
Partnerships
Evaluation
Community
Engagement
Best practices
Engagement Resource
Library
COVID-19 Equity
Evidence Academy
Community of Practice
Community
Collaboration Grants
COVID-19 Testing
Technical support
Repository of emerging
technologies
Testing selection &
implementation
Research pilot studies
Data Science &
Statistics
Data harmonization
Security, privacy, and
protections
Data exchange
Data representation and
visualization
ENGAGEMENT IMPACT TEAMS
CDCC Cores
19. RADx-UP CDCC Engagement ImpactTeams
• Single point-of-contact between CDCC and project teams with
project management & community engagement support
– Coordinating testing, community engagement, and data
collection and sharing resources
– Identifying challenges, collaboratively generating solutions,
sharing best practices
– Collecting required forms (data use agreements, IRB-approved
Informed Consent Forms, etc.)
– Connecting projects with translation services
– Monitoring progress
20. How CDCC and NIH collaborate to support projects
CDCC Engagement
ImpactTeams
• The primary point of
contact at CDCC for each
RADx-UP project
• Community engagement
and project management
NIH Project Officers
& Scientists
• Support in data forms and
grant-related questions
• First point of escalation
CDCC Informaticists
• Coordinate data uploads
by projects
• Perform quality reviews of
project data uploads
• EIT and PO/PS relationships are critical
to RADx-UP success
• EITs copy POs on messages to projects
• POs include EITs in communications
to projects
• When escalation is necessary,
EIT engages PO to facilitate
21. RADx-UP CDCC Community Engagement
• To date
– 450+ participants at COVID-19 Equity Evidence Academy events
– 20+ best practices/guidance documents
– 23 community collaboration grants
– 5+ channels for Community of Practice: Slack, newsletters,
meetings, CCPH consults, working groups
• Key CDCC lesson for this and future pandemics
– Deploying community-engaged projects during a pandemic requires
robust, trusted, and effective research-community partnerships
22. RADx-UPWorking Groups
• RADx-UP projects meet to tackle
topics and challenges that may
commonly occur among similar
populations across the country
• Recently added: Social, Ethical and
Behavioral ImplicationsWorking
Group
is gr7306@comcast.net.
23. Project publications on RADx-UP.org
Highlighting
RADx-UP
publications with
research briefs,
blog posts, video
explainers, and
more
24. RADx-UP Resources
• CDCC continues to collect and create resources
for community-engaged researchers and
community partners
• 132 resources in the collection
• Search by
– Audience
– Topic
– Resource type
• Start at https://radx-up.org/resources/RADx-UP
25. Strategies from the RADx-UP Initiative
• A new policy framework based on
experiences from RADx-UP project teams
• Identifies 5 key actions to address health
inequities in COVID-19 and beyond
• Learn more at
https://radx-up.org/research/health-equity-
framework/
26. Analysis Concepts & Proposals
• Initiative to support the preparation of
collaborative research articles and
presentations that analyze RADx-UP data.
• Consortium members are collaborating in
writing teams with CDCC statistical
support.
• Their publications will help community
leaders and policy makers identify effective
strategies for reducing disparities in COVID-
19 testing and addressing other health
needs of their communities.
27. 2021
MAY
OCT NOV DEC JAN FEB MAR APR
SEP JUN
2022
RADx-UP Key Milestones: Sept. 2021–June 2022
12/2021
Launch of RADx-UP
Colectiv data capture tool
12/1/2021
NEW Community
Consultation
Studio Sessions
1 4
1 2 4
10/2021
RADx-UP Data
Quality Resolution
Policy and Process
1/20/2022
Guidance and Testing Information
re: Delta/Omicron surges
Launch of RADx-UP
Community
Connections Series
10/21/2021
RADx-UP
Scientific
Meeting
11/2021
Guidance and Testing
Information re Ellume
home test recall
NIH RADx-UP CDEs
v1.2 in Spanish
11/17–11/18/2021
RADx-UP COVID-19
Equity Evidence Academy
11/18/2021
You & Me COVID-Free
Program
1 2 3 4
1 2 3 4
1 2 3 4
1 3
1 2 4
1 2 4
1 4
1 2 3
1/2022
RADx-UP Image Bank
Orientation Session
1 2
5/16/2022
RADx-UP Partnering
for Impact
1 4
5/11/2022
RADx-UP Health
Equity Policy
Framework
1 2 3 4
5/3/2022
RADx-UP Scientific
Meeting
1 2 3 4
4/6/2022
NIH RADx-UP
CDEs v1.5
1 4
2/3/2022
Webinar: A Community Engaged
Approach to COVID-19 Testing in
African-American Churches
1 2 3 4
2/14/2022
CDCC New Project
Orientation Session
1 2 3 4
2/17/2022
Engaging Black/
African American Working
Group virtual town hall
1 2 3 4
2/28/2022
67 projects uploaded CDE data to CDCC
4
3/10/2022
RADx-UP Data Dashboard
1 4
3/17/2022
RADx-UP Area-Level
Data Linkage Dashboard
1 4
3/25/2022
RADx-UP.org Redesign
1 2 3 4
Create a community-centered, flexible program infrastructure.
Support a participatory and inclusive community engagement program.
Support research projects with COVID-19 testing guidance and emerging science.
Collect, harmonize, integrate and disseminate data to scientific and local communities.
SPECIFIC
AIMS:
1
2
3
4
4/7/2022
First Data
Transfer to
RADx Data Hub
(data from 2
projects)
4
6/9/2022
Second Transfer to
RADx Data Hub
(data from 53 projects)
4
⭐️
⭐️
⭐️
⭐️
28. Data as of 10/18/2022
at a glance
49
CommunityCollaboration
Mini Grants
127
COVID-19 testing
and SEBI projects
113
Published
research articles
56
States, territories,
and D.C.
1
Coordination & Data
Collection Center
>319,000
Enrolled participants
(prospectively)
16
Rapid Research
Pilot Awards
86
Projects submitting
CDEs to CDCC
>389,000
COVID-19 tests conducted
(prospectively)
29. 29
Key Outcomes per Target Population (Testing + SEBI)
Schools
Participation in weekly testing increases
conscious mitigation behavior
When mitigation strategies are followed,
in-school transmission is low (<1%)
Black and Latino Communities
Latino populations present with greater proportions
of asymptomatic cases as compared to national
average
Black/African Americans in rural areas have lower
testing rates, biasing positivity rates
Black and Latino community populations display
greater vaccine hesitancy – Local leaders should
be engaged to facilitate acceptance and uptake
Lower Socioeconomic
Status
Lower income populations have
reduced motivation to self-test and
distribute testing kits to contacts
32. CDE Development
• Oct. 9, 2020: NIH’s RADx-UP Data Harmonization Guidance received by CDCC, which
included the original RADx-UP Common Data Elements
• Oct. 16, 2020: CDCC team met with the DR2 team to discuss coordination and the CDEs
• Based on initial discussions with NIH RADx-UP leadership, it became clear that the
original CDEs needed to be modified to meet the project and pandemic circumstances:
– Staff and participants were practicing social distancing, with masks
– Vaccines were in development but not yet available
– Moving into winter 2020, with a surge in cases and deaths expected
– Many of the Projects had finalized their protocols and were awaiting IRB approval
• CDEs needed to collect key data while also limiting risk and burden for the
participants and Project teams
33. CDE Development
• Oct. & Nov. 2020: CDCC and NIH worked to revise and pare down the
number of CDEs
• Dec. 3, 2020: draft version of the CDEs shared with the projects
RADx-UPCDE Categories
• Sociodemographics and consent
• Housing, Employment and Insurance
• Medical History
• Medications
• Symptoms
• Health Status (includingAlcohol andTobacco)
• Disability
• Vaccine Hesitancy
• Identity
34. CDE Development
• Dec. 8, 2020: CDE Feedback survey sent to the Projects
• Dec 14, 2020: Deadline for Projects to complete the survey
• Dec. 15, 2020: CDCC reviewed and consolidated feedback and
recommendations
• Dec. 17, 2020: RADx-UP Project-wide Meeting at which
CDE feedback was discussed
35. 13
52
Feedback Survey Questions and Results (Dec 2020)
31
10
7 8
25
9 8
19 18
22
42
8
0
5
10
15
20
25
30
35
40
45
Identity Consent Symptoms
(COVID-19)
Demographics Disability Employment Health
Insurance
Health Status Housing Medical History Medications Vaccine
Hesitancy
Which category or categories contain
questions you anticipate not being able
to collect?
36. CDE Development
• Dec. 18, 2020 – Jan. 2021: CDCC and NIH incorporate Project feedback
and finalize the CDEs. Major changes included:
– Ethnicity (subcategories added for Asian, Native Hawaiian/Pacific Islander, and Hispanic),
– Sexual orientation and gender identity questions added and terminology better aligned with
communities
– Housing questions clarified and made more relevant to RADx-UP populations
– Employment questions made more relevant to COVID-19 pandemic conditions
– Health insurance question expanded to include type of insurance
– COVID-19 pandemic-related questions added (hardship, PPE, distancing, COVID testing,
COVID symptoms, vaccine acceptance)
– Spoken language questions added
– Medical history questions focused on items relevant to COVID-19
– Medications, vaccine hesitancy, and most of the disability and alcohol/tobaccos questions
were moved toTier 2.
Sources of these CDEs included PhenX, DR2, NIH CDE Repository, and the RADx-UP Projects
37. Tier 1 CDEs
Required from
all testing
Projects
• Consent
• Location (new)
• Sociodemographics
• Housing, Employment and
Insurance
• Work PPE and Distancing (new)
• Medical History
• Health Status
• VaccineAcceptance
• Testing (new)
• COVIDTest (new)
• Symptoms
• Alcohol &Tobacco
• Identity
Tier 2 CDEs
Recommended
additionalCDEs
• Sociodemographics
• Medical History
• VaccineAcceptance
• Testing
• Medications
• Alcohol andTobacco
• Drug Use
• Disability
• Food Insecurity
• Housing
• Trust
• Identity – SSN and MRN
• Two components:
• CDEs recorded by the participants or Project teams
• CDEs recorded by the Project teams
• Available as REDCap codebook PDF or CSV data dictionary, or PDF forms for paper data collection
38. CDE Development
• Jan. 4, 2021: CDEs v.1.0 released to the Projects and
made publicly available on RADx-UP.org
• Feb. 9-17, 2021: NIH CDETracking Form released,
which the Projects could use to request individual or
group CDE exceptions and wording changes.
• Feb. 2021: CDCC’s Data Submission Guidance
document v1.0 released.
• EITs and Informaticists began training and providing
support for CDE implementation.
39. CDE Revisions
Version Release Date Major Changes
1.1 Aug. 12, 2021 Wording, responses, and branching logic fixes
1.2 Sep. 28, 2021 Added vaccine acceptance and administration questions
1.3 Incorporated into 1.4
1.4 Feb. 9, 2022 Added “prefer not to answer” to more questions, existing CDEs
modified for pediatric use, and new Pediatric CDEs
1.5 Apr. 6, 2022 Wording, responses, and branching logic fixes
1.6 Oct. 27, 2022 Additional disability questions moved toTier 1
Any new or revisedTier 1 CDEs are only required for projects that were awarded after the CDE release date
40. CDE Intake and Quality Checks
• The REDCap codebooks along with the NIH CDE
Tracking Form have been the basis around which we
have built our repository, data quality and
conformance checks, reporting and dashboards, and
analysis datasets.
• Projects upload their data through our portal
(myRADx-Uphome) and get immediate, detailed
data quality reports that they use to identify and
resolve issues in their CDE data.
41. RADx-UP Data Intake Status
• As of Nov 1, 2022:
– 99 Projects have uploaded CDE data files
– 641,404 participants’ data in our database (not including EHR data)
– Using 5,310 project participants’ zip codes, the CDCC has linked to
external social determinants of health datasets:
Area deprivation index (ADI)
Agency for Healthcare Research and Quality (AHRQ)
SocialVulnerability Index (SVI)
ChildOpportunity Index (COI)
PandemicVulnerability Index (PVI)
Minority Health SVI
vaccination data from cdc.gov
42. Benefits of the RADx-UP CDEs
• The CDEs allowed for accelerated intake, harmonization, and use of data:
– January 2021: CDEs released
– March 2021: First data upload to CDCC
– March 2022: RADx-UP Data Dashboard launched (visualizations using CDE data)
– April 2022: First data upload from CDCC to the RADx Data Hub
– September 2022: Core Analytic Datasets available usingTier 1 CDE data
– October 2022: First consortia datasets delivered to writing team for analysis
• For the most part, projects were able to quickly understand and resolve data
quality and conformance issues. After a few uploads the number of data issues
drop significantly.
• We have given all newer versions of a CDE its own identifier, so we can trace
exactly which version of a CDE was given to a participant and allow projects to
update to new versions of the CDEs on their own timeline.
43. 43
To date:
•NIH, CDCC, and RADx-UP (Phase I) projects collaborated to
develop the NIH RADx-UP Common Data Elements, from 700+ →
60+
•Currently, 99 projects are transferring study data and RADx-UP
NIH CDEs to the CDCC data repository
•CDE Dashboard provides a window to the aggregated data, will
inform consortium publications
Key CDCC lesson for this and future pandemics
•Developing CDEs during a pandemic is challenging
•Engaging projects and community partners is critical to
success
RADx-UP CDCC Data Science & Biostatistics Core
48. CDE and Data ManagementTakeaways
• For community-engaged research, bidirectional communication and
collaboration between researchers, communities, and participants helps
with understanding, acceptance, and uptake of CDEs
• Collaboration also ensures that the CDEs accurately reflect the people
and communities who are taking part in the research
• Participant and study staff burden and risk are important concerns for
data collection in a pandemic
• CDEs are the foundation – however ingesting data from multiple
independent projects with many different experimental designs and
scientific goals still requires robust data quality and conformance
training, education, monitoring, and review processes
49. • For encouraging testing and vaccination, culturally appropriate
education is important to increase trust in official sources of
COVID-19 information
• Community Advisory Boards have provided key
recommendations and support
• Community engagement and trust are essential to ensure the
success of COVID-19 testing and vaccination programs
• Flexibility and the ability to adapt is critical
• Partnerships with community health clinics provide a
necessary connection to underserved populations
Lessons Learned for Future Success
Rapid Acceleration of Diagnostics - Underserved Populations
The data is easy to follow on the website: https://covid.cdc.gov/covid-data-tracker/#demographicsovertime
This shows the hospitalization rate:
https://covid.cdc.gov/covid-data-tracker/#covidnet-hospitalization-network
The Urban vs. Rural breakdown and the child hospitalization rate:
https://covid.cdc.gov/covid-data-tracker/#pop-factors_7daynewcases
The data is easy to follow on the website: https://covid.cdc.gov/covid-data-tracker/#demographicsovertime
This shows the hospitalization rate:
https://covid.cdc.gov/covid-data-tracker/#covidnet-hospitalization-network
The Urban vs. Rural breakdown and the child hospitalization rate:
https://covid.cdc.gov/covid-data-tracker/#pop-factors_7daynewcases
CDCC supports over 88 research projects touching all states and U.S. territories
CDCC supports over 88 research projects touching all states and U.S. territories
EITs and PO/PS relationship: EITs eager to work closely with PO to support project teams
Project Orientation: Attend orientation to understand expectations, roles, and get to know your project team via breakout sessions
Project’s progress: Be included in EIT emails to projects and project meetings to stay abreast of project’s progress
Project Communication: PO’s to include EITs in their communication - CDE exemption status letter
First point of escalation when project team needs additional support to resolve challenges
127 total RADx-UP projects: Phase I (69), Phase II (37), Supplemental (21)
Enrolled participants source: CDE data
COVID-19 tests conducted source: CDE data
Territories include sites in Guam, American Samoa, Northern Mariana Islands, US Virgin Islands, and Puerto Rico
Giselle
Please note that the presentation is only focused on CDEs.
Third box: CDE data collection